Stay updated on Onasemnogene for SMA: Intrathecal Clinical Trial
Sign up to get notified when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.

Latest updates to the Onasemnogene for SMA: Intrathecal Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page received a new site revision notice (Revision: v3.4.2) and an older notice (Revision: v3.4.1) was removed; these changes affect only site messaging and do not modify the study details, eligibility criteria, or data displayed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check15 days agoChange DetectedAdded a government-funding site status notice and updated the page version to v3.4.1 (replacing v3.4.0).SummaryDifference0.4%

- Check23 days agoChange DetectedThe page now includes a glossary feature and a plain-language trial summary link (novctrd.com), with the revision updated to v3.4.0 and the latest QC submission dated 2026-01-26. The older QC date (2023-04-24) and No FEAR Act data entries were removed.SummaryDifference0.4%

- Check37 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. The study details and page structure remain unchanged.SummaryDifference0.0%

- Check58 days agoChange DetectedLocations now list multiple states (California, Florida, Illinois, Maryland, Massachusetts, Missouri, Ohio, Pennsylvania, Texas, Utah) on the study page, and the revision tag shows v3.3.3.SummaryDifference1%

- Check86 days agoChange DetectedPage revision updated from v3.2.0 to v3.3.2; this minor update does not alter study content or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Onasemnogene for SMA: Intrathecal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Onasemnogene for SMA: Intrathecal Clinical Trial page.